Sepsis induces albuminuria and alterations in the glomerular filtration barrier: a morphofunctional study in the rat

Critical Care

Volumn 15, Issue 6, 2011, Pages

  Adembri, Chiara ^a   Sgambati, Eleonora ^b   Vitali, Luca ^a   Selmi, Valentina ^a   Margheri, Martina ^c   Tani, Alessia ^c   Bonaccini, Laura ^c   Nosi, Daniele ^c   Caldini, Anna L ^a   Formigli, Lucia ^c   De Gaudio, Angelo R ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; HYALURONIC ACID; LECTIN; SIALIC ACID; SYNDECAN 1; TUMOR NECROSIS FACTOR ALPHA; N ACETYLNEURAMINIC ACID; SDC1 PROTEIN, RAT;

ACETYLATION; ALBUMINURIA; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CECUM; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; GLOMERULUS; GLOMERULUS FILTRATION; GLYCOCALYX; HISTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; LIGATION; MALE; MICROORGANISM; NONHUMAN; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCTURE; RAT; SEPSIS; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; ANIMAL; ASCITES FLUID; BLOOD; CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULAR FILTRATION BARRIER; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; ULTRASTRUCTURE;

ALBUMINURIA; ANIMALS; ASCITIC FLUID; CREATININE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULAR FILTRATION BARRIER; MALE; N-ACETYLNEURAMINIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SYNDECAN-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81455160578     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10559     Document Type: Article

References (58)

1. Parrillo JE. The cardiovascular pathophysiology of sepsis. Annu Rev Med 1989, 40:469-485. 10.1146/annurev.me.40.020189.002345, 2658761.
2. Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008, 83:536-545.
3. Czabanka M, Peter C, Martin E, Walther A. Microcirculatory endothelial dysfunction during endotoxemia--insights into pathophysiology, pathologic mechanisms and clinical relevance. Curr Vasc Pharmacol 2007, 5:266-275. 10.2174/157016107782023389, 17979793.
4. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101:3765-3777. 10.1182/blood-2002-06-1887, 12543869.
5. Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009, 37:840-851. quiz 859, 10.1097/CCM.0b013e3181961bff, 19237886.
6. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003, 83:253-307.
7. Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008, 88:451-487. 10.1152/physrev.00055.2006, 18391170.
8. Vink H, Duling BR. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Physiol Heart Circ Physiol 2000, 278:H285-289.
9. Jeansson M, Haraldsson B. Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. Am J Physiol Renal Physiol 2006, 290:F111-116.
10. Singh A, Satchell SC, Neal CR, McKenzie EA, Tooke JE, Mathieson PW. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol 2007, 18:2885-2893. 10.1681/ASN.2007010119, 17942961.
11. Song XM, Wang YL, Li JG, Wang CY, Zhou Q, Zhang ZZ, Liang H. Effects of propofol on pro-inflammatory cytokines and nuclear factor kappaB during polymicrobial sepsis in rats. Mol Biol Rep 2009, 36:2345-2351. 10.1007/s11033-009-9456-z, 19190997.
12. Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 2007, 454:345-359. 10.1007/s00424-007-0212-8, 1915585, 17256154.
13. Varki A. Essentials of glycobiology 2009, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2.
14. Singleton PA, Mirzapoiazova T, Guo Y, Sammani S, Mambetsariev N, Lennon FE, Moreno-Vinasco L, Garcia JG. High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness. Am J Physiol Lung Cell Mol Physiol 2010, 299:L639-651. 10.1152/ajplung.00405.2009, 2980391, 20709728.
15. Bruegger D, Schwartz L, Chappell D, Jacob M, Rehm M, Vogeser M, Christ F, Reichart B, Becker BF. Release of atrial natriuretic peptide precedes shedding of the endothelial glycocalyx equally in patients undergoing on- and off-pump coronary artery bypass surgery. Basic Res Cardiol
16. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3:97-130. 10.1093/glycob/3.2.97, 8490246.
17. Varki A. Sialic acids as ligands in recognition phenomena. FASEB J 1997, 11:248-255.
18. Gabrielli MG, Bondi AM, Materazzi G, Menghi G. Differential location and structural specificities of sialic acid-beta-D-Gal sequences belonging to sialoderivatives of rabbit oviduct under hormonal treatment. Histol Histopathol 2004, 19:1175-1186.
19. Varki A. Diversity in the sialic acids. Glycobiology 1992, 2:25-40. 10.1093/glycob/2.1.25, 1550987.
20. Accili D, Menghi G, Gabrielli MG. Lectin histochemistry for in situ profiling of rat colon sialoglycoconjugates. Histol Histopathol 2008, 23:863-875.
21. Schauer R. Sialic acids as regulators of molecular and cellular interactions. Curr Opin Struct Biol 2009, 19:507-514. 10.1016/j.sbi.2009.06.003, 19699080.
22. Schauer R. Sialic acids: fascinating sugars in higher animals and man. Zoology (Jena) 2004, 107:49-64.
23. Schulte BA, Spicer SS. Histochemical methods for characterizing secretory and cell surface sialoglycoconjugates. J Histochem Cytochem 1985, 33:427-438. 10.1177/33.5.3989272, 3989272.
24. Schulte BA, Spicer SS, Miller RL. Lectin histochemistry of secretory and cell-surface glycoconjugates in the ovine submandibular gland. Cell Tissue Res 1985, 240:57-66.
25. Angata T, Varki A. Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem Rev 2002, 102:439-469. 10.1021/cr000407m, 11841250.
26. Galeano B, Klootwijk R, Manoli I, Sun M, Ciccone C, Darvish D, Starost MF, Zerfas PM, Hoffmann VJ, Hoogstraten-Miller S, Krasnewich DM, Gahl WA, Huizing M. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. J Clin Invest 2007, 117:1585-1594. 10.1172/JCI30954, 1878529, 17549255.
27. Quaggin SE. Sizing up sialic acid in glomerular disease. J Clin Invest 2007, 117:1480-1483. 10.1172/JCI32482, 1878540, 17549251.
28. Gelberg H, Healy L, Whiteley H, Miller LA, Vimr E. In vivo enzymatic removal of alpha 2-->6-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury. Lab Invest 1996, 74:907-920.
29. Takeda T. Podocyte cytoskeleton is connected to the integral membrane protein podocalyxin through Na+/H+-exchanger regulatory factor 2 and ezrin. Clin Exp Nephrol 2003, 7:260-269. 10.1007/s10157-003-0257-8, 14712354.
30. Harvey SJ, Miner JH. Revisiting the glomerular charge barrier in the molecular era. Curr Opin Nephrol Hypertens 2008, 17:393-398. 10.1097/MNH.0b013e32830464de, 18660676.
31. Broekhuizen LN, Lemkes BA, Mooij HL, Meuwese MC, Verberne H, Holleman F, Schlingemann RO, Nieuwdorp M, Stroes ES, Vink H. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia 2010, 53:2646-2655. 10.1007/s00125-010-1910-x, 2974920, 20865240.
32. Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JA, Ince C, Holleman F, Diamant M, Heine RJ, Hoekstra JB, Kastelein JJ, Stroes ES, Vink H. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 2006, 55:1127-1132. 10.2337/diabetes.55.04.06.db05-1619, 16567538.
33. Chappell D, Jacob M, Hofmann-Kiefer K, Bruegger D, Rehm M, Conzen P, Welsch U, Becker BF. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007, 107:776-784. 10.1097/01.anes.0000286984.39328.96, 18073553.
34. White LE, Chaudhary R, Moore LJ, Moore FA, Hassoun HT. Surgical sepsis and organ crosstalk: the role of the kidney. J Surg Res 2011, 167:306-315. 10.1016/j.jss.2010.11.923, 21324390.
35. Wan L, Bellomo R, Di Giantomasso D, Ronco C. The pathogenesis of septic acute renal failure. Curr Opin Crit Care 2003, 9:496-502. 10.1097/00075198-200312000-00006, 14639069.
36. De Gaudio AR, Adembri C, Grechi S, Novelli GP. Microalbuminuria as an early index of impairment of glomerular permeability in postoperative septic patients. Intensive Care Med 2000, 26:1364-1368. 10.1007/s001340000593, 11089766.
37. Chappell D, Hofmann-Kiefer K, Jacob M, Rehm M, Briegel J, Welsch U, Conzen P, Becker BF. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol 2009, 104:78-89. 10.1007/s00395-008-0749-5, 18836678.
38. Cioffi DL, Lowe K, Alvarez DF, Barry C, Stevens T. TRPing on the lung endothelium: calcium channels that regulate barrier function. Antioxid Redox Signal 2009, 11:765-776. 10.1089/ars.2008.2221, 2850299, 18783312.
39. Marechal X, Favory R, Joulin O, Montaigne D, Hassoun S, Decoster B, Zerimech F, Neviere R. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 2008, 29:572-576.
40. Cabrales P, Vazquez BY, Tsai AG, Intaglietta M. Microvascular and capillary perfusion following glycocalyx degradation. J Appl Physiol 2007, 102:2251-2259. 10.1152/japplphysiol.01155.2006, 17347383.
41. Kato T, Mizuno S, Kamimoto M. The decreases of nephrin and nuclear WT1 in podocytes may cause albuminuria during the experimental sepsis in mice. Biomed Res 2010, 31:363-369. 10.2220/biomedres.31.363, 21187647.
42. Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov 2005, 4:854-865. 10.1038/nrd1854, 16224456.
43. Shibuya N, Goldstein IJ, Broekaert WF, Nsimba-Lubaki M, Peeters B, Peumans WJ. Fractionation of sialylated oligosaccharides, glycopeptides, and glycoproteins on immobilized elderberry (Sambucus nigra L.) bark lectin. Arch Biochem Biophys 1987, 254:1-8. 10.1016/0003-9861(87)90074-9, 3579290.
44. Wang WC, Clark GF, Smith DF, Cummings RD. Separation of oligosaccharides containing terminal alpha-linked galactose residues by affinity chromatography on Griffonia simplicifolia I bound to concanavalin A-sepharose. Anal Biochem 1988, 175:390-396. 10.1016/0003-2697(88)90562-3, 3239769.
45. Mencucci R, Marini M, Gheri G, Vichi D, Sarchielli E, Bonaccini L, Ambrosini S, Zappoli Thyrion GD, Paladini I, Vannelli GB, Sgambati E. Lectin binding in normal, keratoconus and cross-linked human corneas. Acta Histochem 2010,
46. Brooks HF, Osabutey CK, Moss RF, Andrews PL, Davies DC. Caecal ligation and puncture in the rat mimics the pathophysiological changes in human sepsis and causes multi-organ dysfunction. Metab Brain Dis 2007, 22:353-373. 10.1007/s11011-007-9058-1, 17828620.
47. Venturi L, Miranda M, Selmi V, Vitali L, Tani A, Margheri M, De Gaudio AR, Adembri C. Systemic sepsis exacerbates mild post-traumatic brain injury in the rat. J Neurotrauma 2009, 26:1547-1556. 10.1089/neu.2008.0723, 19257801.
48. Doi K, Leelahavanichkul A, Yuen PS, Star RA. Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 2009, 119:2868-2878. 10.1172/JCI39421, 2752080, 19805915.
49. Bernard A, Ouled Amor A, Lauwerys R. Charge-dependent renal uptake of beta 2-microglobulin in conscious rats. Scand J Clin Lab Invest 1992, 52:415-423. 10.3109/00365519209088377, 1325071.
50. Skutelsky E, Hartzan S, Socher R, Gafter U. Modifications in glomerular polyanion distribution in adriamycin nephrosis. J Am Soc Nephrol 1995, 5:1799-1805.
51. Kwak DH, Rho YI, Kwon OD, Ahan SH, Song JH, Choo YK, Kim SJ, Choi BK, Jung KY. Decreases of ganglioside GM3 in streptozotocin-induced diabetic glomeruli of rats. Life Sci 2003, 72:1997-2006. 10.1016/S0024-3205(03)00090-0, 12597998.
52. Henry CB, Duling BR. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 2000, 279:H2815-2823.
53. Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 2008, 30:623-627. 10.1097/SHK.0b013e3181777da3, 18497712.
54. Oragui EE, Nadel S, Kyd P, Levin M. Increased excretion of urinary glycosaminoglycans in meningococcal septicemia and their relationship to proteinuria. Crit Care Med 2000, 28:3002-3008. 10.1097/00003246-200008000-00054, 10966286.
55. Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T, Jourdain M, Pugin J, Tonnel AB, Lassalle P. Endocan, a new endothelial marker in human sepsis. Crit Care Med 2006, 34:532-537. 10.1097/01.CCM.0000198525.82124.74, 16424738.
56. Henry CB, Duling BR. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol 1999, 277:H508-514.
57. Jarad G, Miner JH. Albuminuria, wherefore art thou?. J Am Soc Nephrol 2009, 20:455-457. 10.1681/ASN.2009010075, 19244573.
58. Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol 2007, 81:137-143.